Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...
Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a leading stock. Explore the latest updates on Sun Pharma stock, including: Last ...
Sun Pharmaceutical and its Taro Pharmaceutical subsidiary are washing their hands of another segment of a years-long antitrust debacle with a $200 million settlement. The deal will clear all claims ...
Hosted on MSN
Sun Pharma clarifies $10 bn Organon acquisition report, calls it 'speculative in nature'
Sun Pharmaceutical Industries Ltd on Monday clarified on media reports about a possible $10 billion acquisition of US-based Organon, calling them 'speculative in nature'. The company said there is no ...
July 31 (Reuters) - Sun Pharmaceutical Industries (SUN.NS), opens new tab, India's largest drugmaker by revenue, reported a higher adjusted profit on Thursday, aided by strong domestic sales. The ...
Hosted on MSN
Sun Pharma: What JM Financial says as Halol plant gets OAI tag; check key stock drivers
Shares of Sun Pharmaceutical Industries Ltd declined in Wednesday’s trade as the company disclosed that the US Food and Drug Administration (US FDA) has classified its Halol facility as Official ...
Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...
July 14 (Reuters) - India's top drugmaker by revenue Sun Pharma (SUN.NS), opens new tab on Monday launched its anti-baldness drug Leqselvi in the U.S., following the settlement of a patent dispute ...
India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE: OGN), a U.S.-based women's healthcare company. If it goes through, the deal that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results